VAERS 2088490
PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN5813
- Staat
- TX
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 04.02.2022
- Impfdatum
- 13.02.2021
- Beginn
- 25.01.2022
- Tage bis Beginn
- 346,0
- Dosis
- 2
- Route/Site
- IM / LA
Symptomtext
Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 01/23/21 and 02/13/2021. COVID + on 1/10/22. Presented to ED on 1/17/2022 with acute hypoxic respiratory failure 2/2 COVID-19 and needed 2L on admit. Presented with malaise and SOB x 1 week. Previously admitted on 1/10/22 and treated with Decadron. CXR showed worsening bilateral pulmonary opacities given Lasix and also received supplemental O2 via HFNC +NC. Code status changed to DNAR. Patient expired on 1/25/22
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 8,0
- Labordaten
- 1/10/22 Covid-19 +: This sample was analyzed using the BioFire Torch system using PCR or equivalent Nucleic Acid Amplification (NAA) technology.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- HFpEF, DM2, CKD5, HTN
- Andere Medikamente
- amlodipine, atorvastatin, Vitamin D3, clonidine, dulaglutide, ferrous sulfate, hydralazine, insulin glargine, lisinopril, sodium bicarbonate, torsemide
- Allergien
- NKDA
- Vorherige Impfungen
- -